Fibroblast Growth Factor-23 (FGF23) Reduction in Predialysis Chronic Kidney Disease (CKD)
Clinical trial NCT00843349 · COMPLETED
Trial details
- NCT number
- NCT00843349
- Sponsor
- Myles Wolf
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2009-07-01
- Primary completion
- 2012-02-01
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.